The DOI matches its Crossref record; 63 of the 70 references it cites were found in a registry or an index.
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
Open accessAbstract
The switch to an angiogenic phenotype is a fundamental determinant of neoplastic growth and tumor progression. We demonstrate that homozygous deletion of the p53 tumor suppressor gene via homologous recombination in a human cancer cell line promotes the neovascularization and growth of tumor xenografts in nude mice. We find that p53 promotes Mdm2-mediated ubiquitination and proteasomal degradation of the HIF-1α subunit of hypoxia-inducible factor 1 (HIF-1), a heterodimeric transcription factor that regulates cellular energy metabolism and angiogenesis in response to oxygen deprivation. Loss of p53 in tumor cells enhances HIF-1α levels and augments HIF-1-dependent transcriptional activation of the vascular endothelial growth factor (VEGF) gene in response to hypoxia. Forced expression of HIF-1α in p53-expressing tumor cells increases hypoxia-induced VEGF expression and augments neovascularization and growth of tumor xenografts. These results indicate that amplification of normal HIF-1-dependent responses to hypoxia via loss of p53 function contributes to the angiogenic switch during tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Apart from canonical HRE-mediated transcription, the HIF isoforms differentially modulate signaling pathways through interaction with proteins that do not contain PAS domains, such p53, the c-MYC proto-oncogene, β-catenin and the Notch intracellular domain (Fig. 2A) [11–15].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [11]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Intriguingly, p53 can also promote Mdm2-mediated degradation of HIF-1α (Ravi et al., 2000).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Ravi et al., 2000
The cited source says what the claim attributes to it.
In the citing paper
“It has been proposed that MDM2 can also ubiquitinate and degrade HIF-1α through the proteasome pathway”
From Stress Response of Glioblastoma Cells Mediated by miR-17-5p Targeting PTEN and the Passenger Strand miR-17-3p Targeting MDM2 (2012) · cites this paper as [56]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“which raises the possibility that miR-17 mediates cellular response to diverse stimuli by targeting closely related signaling pathways [56].”
From Stress Response of Glioblastoma Cells Mediated by miR-17-5p Targeting PTEN and the Passenger Strand miR-17-3p Targeting MDM2 (2012) · cites this paper as [56]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Self-citationThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Self-citationKim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“…ligase and is itself a target for Ub-mediated degradation via its interaction with Mdm2 (Momand et al. 1992; Barak et al. 1993; Wu et al. 1993; Haupt et al. 1997; Honda et al. 1997; Kubbutat et al. 1997), this raised the possibility that HIF-1a is recruited to Mdm2 via its interaction with p53.”
Background
Research works printed but not linked: 3
- Kubbutat, 1997, Regulation of p53 stability by Mdm2., Nature, 387, 299, 10.1038/387299a0 · DOI · Paper page
- Ravi, 1998, p53-mediated repression of nuclear factor κ-B RelA via the transcriptional integrator p 300., Cancer Res., 58, 4531
- Zhong, 1999, Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases., Cancer Res., 59, 5830
Cited by
Sorted by citations
Items 501–600 of 967
Molecular Mechanisms and Targets of Therapy for Hepatocellular Carcinoma
Klungboonkrong, V., Das, D., & McLennan, G. (2017) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2017.03.002 · Cited by 41
Regulation of Signal Transduction by DJ-1
Oh, S. E., & Mouradian, M. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6583-5_8 · Cited by 44
Dual regulation of energy metabolism by p53 in human cervix and breast cancer cells
Hernández‐Reséndiz, I., Román-Rosales, A., Garcı́a-Villa, E., López-Macay, Á., Pineda, E., Saavedra, E., Gallardo‐Pérez, J. C., Álvarez-Ríos, E., Gariglio, P., Moreno‐Sánchez, R., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.09.033 · Cited by 42
Lau, C. K., Yang, Z. F., Lam, C. T., Tam, K. H., Poon, R. T. P., & Fan, S. T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.015 · Cited by 43
Zhang, L., Jiang, Z., Yang, X., Qian, Y., Wang, M., Wu, S., Li, L., Jia, F., Wang, Z., Hu, Z., et al. (2022) · Advanced Materials · doi:10.1002/adma.202207330 · Cited by 42
Zeng, L., Kizaka‐Kondoh, S., Itasaka, S., Xie, X., Inoue, M., Tanimoto, K., Shibuya, K., & Hiraoka, M. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00537.x · Cited by 41
Cardiac pressure overload hypertrophy is differentially regulated by β-adrenergic receptor subtypes
Zhao, M., Fajardo, G., Urashima, T., Spin, J. M., Poorfarahani, S., Rajagopalan, V., Huynh, D. T. N., Connolly, A. J., Quertermous, T., & Bernstein, D. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00453.2010 · Cited by 41
The Interaction Between Human Papillomaviruses and the Stromal Microenvironment
Woodby, B. L., Scott, M. L., & Bodily, J. M. (2016) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.09.003 · Cited by 41
Elevated Serum Level of IL-23 Correlates with Expression of VEGF in Human Colorectal Carcinoma
Ljujić, B., Radosavljevic, G. D., Jovanović, I., Pavlovic, S. M., Zdravkovic, N. S., Milovanović, M., Aćimović, L., Knežević, M., Banković, D., Zdravkovic, D., et al. (2010) · Archives of Medical Research · doi:10.1016/j.arcmed.2010.02.009 · Cited by 41
Cell Permeable Iron Chelators as Potential Cancer Chemotherapeutic Agents
Pahl, P. M. B., & Horwitz, L. D. (2005) · Cancer Investigation · doi:10.1080/07357900500359976 · Cited by 40
MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy
Shridhar, P., Glennon, M. S., Pal, S., Waldron, C. J., Chetkof, E. J., Basak, P., Clavere, N. G., Banerjee, D., Gingras, S., & Becker, J. R. (2023) · Circulation · doi:10.1161/circulationaha.123.064332 · Cited by 42
Nur77 upregulates HIF-α by inhibiting pVHL-mediated degradation
Kim, B.-Y., Kim, H., Cho, E., & Youn, H. (2008) · Experimental & Molecular Medicine · doi:10.3858/emm.2008.40.1.71 · Cited by 40
Jiang, Y., Wang, J., TIAN, H., Li, G., Zhu, H., Liu, L., Hu, R., & Dai, A. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2209 · Cited by 41
Roudier, E. A., Forn, P., Perry, M. E., & Birot, O. (2012) · The FASEB Journal · doi:10.1096/fj.12-212720 · Cited by 43
The functional interplay between the HIF pathway and the ubiquitin system – more than a one-way road
Günter, J., Ruiz‐Serrano, A., Pickel, C., Wenger, R. H., & Scholz, C. C. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.027 · Cited by 40
Rodrı́guez, C., Puente‐Moncada, N., Reiter, R. J., Sánchez‐Sánchez, A. M., Herrera, F., Rodríguez‐Blanco, J., Duarte‐Olivenza, C., Turos‐Cabal, M., Antolı́n, I., & Martı́n, V. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29886 · Cited by 40
Hypoxia-Inducible Factor (HIF): Fuel for Cancer Progression
Satija, S., Kaur, H., Tambuwala, M. M., Sharma, P., Vyas, M., Khurana, N., Sharma, N., Bakshi, H. A., Charbe, N. B., Zacconi, F. C. M., et al. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666210120154929 · Cited by 40
Endogenous Hypoxia Markers: Case Not Proven!
Mayer, A., Höckel, M., & Vaupel, P. W. (2008) · Springer eBooks · doi:10.1007/978-0-387-74911-2_15 · Cited by 40
Purified recombinant hARD1 does not catalyse acetylation of Lys532 of HIF‐1α fragments in vitro
Murray-Rust, T. A., Oldham, N. J., Hewitson, K. S., & Schofield, C. J. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.02.012 · Cited by 41
Hypoxia inducible factor (HIF) as a model for studying inhibition of protein–protein interactions
Burslem, G. M., Kyle, H. F., Nelson, A., Edwards, T. A., & Wilson, A. J. (2017) · Chemical Science · doi:10.1039/c7sc00388a · Cited by 39
Luo, W., Chen, I., Chen, Y., Alkam, D., Wang, Y., & Semenza, G. L. (2016) · Oncotarget · doi:10.18632/oncotarget.7142 · Cited by 39
Self-citationRoth, I. M., Campbell, H., Cortés-Rubio, C. N., Vennin, C., Wilson, M., Wiles, A. K., Williams, G., Woolley, A. G., Timpson, P., Berridge, M. V., et al. (2016) · Oncogene · doi:10.1038/onc.2016.45 · Cited by 39
Protein networks linking Warburg and reverse Warburg effects to cancer cell metabolism
Johar, D., Elmehrath, A. O., Khalil, R. M., Elberry, M. H., Zaky, S., Shalabi, S. A., & Bernstein, L. H. (2021) · BioFactors · doi:10.1002/biof.1768 · Cited by 42
Perinatal asphyxia in the rat has lifelong effects on morphology, cognitive functions, and behavior
Weitzdoerfer, R., Pollak, A. J., & Lubec, B. (2004) · Seminars in Perinatology · doi:10.1053/j.semperi.2004.08.001 · Cited by 39
MDM2 309 polymorphism is associated with missed abortion
Fang, Y., Kong, B., Yang, Q., Ma, D., & Qu, X. (2009) · Human Reproduction · doi:10.1093/humrep/dep044 · Cited by 39
Hypoxia-Inducible Factor-1 and p53: Friends, Acquaintances, or Strangers?
Hammond, E. M., & Giaccia, A. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0613 · Cited by 41
Metabolic Roles of HIF1, c-Myc, and p53 in Glioma Cells
Trejo‐Solís, C., Castillo‐Rodríguez, R. A., Serrano-García, N., Silva‐Adaya, D., Vargas-Cruz, S., Chávez-Cortéz, E. G., Gallardo‐Pérez, J. C., Zavala-Vega, S., Cruz-Salgado, A., & Magaña-Maldonado, R. (2024) · Metabolites · doi:10.3390/metabo14050249 · Cited by 41
Epigenetic regulation of hypoxia inducible factor in diseases and therapeutics
Nguyen, M. P., Lee, S., & Lee, Y. M. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0058-x · Cited by 37
Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy
Li, X.-M., Zhao, Z., Xiao, Y., Xia, Q., Zhou, P., Wang, S., Wu, H., & Hu, J. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00394-2 · Cited by 40
Ma, J., Liu, W., Yan, X., Wang, Q., Zhao, Q., Xue, Y., Ren, H. J., Wu, L., Cheng, Y., Li, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032368 · Cited by 39
RetractedMalhotra, R., Tyson, D. G. W., Sone, H., Aoki, K., Kumagai, A. K., & Brosius, F. C. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2047 · Cited by 38
Abreu, P. L., Ferreira, L. M. R., Alpoim, M. C., & Urbano, A. M. (2014) · BioMetals · doi:10.1007/s10534-014-9726-7 · Cited by 39
Hypoxia and oxidative stress in breast cancer Hypoxia signalling pathways
Pugh, C. W., Gleadle, J., & Maxwell, P. H. (2001) · Breast Cancer Research · doi:10.1186/bcr313 · Cited by 38
Proceedings of the Oxygen Homeostasis/Hypoxia Meeting
Kaufman, B. M., Scharf, O., Arbeit, J. M., Ashcroft, M. A., Brown, J. M., Bruick, R. K., Chapman, J. D., Evans, S. M., Giaccia, A. J., Harris, A. L., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2611 · Cited by 39
Self-citationVon Hippel-Lindau disease: gene to bedside
Sims, K. B. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200112000-00004 · Cited by 38
Hypoxia signaling in the adipose tissue
Huynh, P. M., Wang, F., & An, Y. (2024) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjae039 · Cited by 42
Mohammed, Y. H. I., Malojirao, V. H., Thirusangu, P., Al‐Ghorbani, M., Prabhakar, B. T., & Khanum, S. A. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.10.082 · Cited by 37
Tumor Endothelial Cell—A Biological Tool for Translational Cancer Research
Annan, D. A., Kikuchi, H., Maishi, N., Hida, Y., & Hida, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093238 · Cited by 38
Pei, X., Chu, M., Tang, P., Zhang, H., Zhang, X., Zheng, X., Li, J., Mei, J., Wang, T., & Yin, S. (2021) · Fish Physiology and Biochemistry · doi:10.1007/s10695-021-00989-8 · Cited by 36
Bruno, A., Pagani, A., Magnani, E., Rossi, T., Noonan, D. M., Cantelmo, A. R., & Albini, A. (2013) · Cancer treatment and research · doi:10.1007/978-3-642-38007-5_23 · Cited by 37
Zhang, R., Cao, Y., Bai, L., Zhu, C., Li, R., He, H., Liu, Y., Wu, K., Liu, F., & Wu, J. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22229 · Cited by 37
Leu-574 of HIF-1α Is Essential for the von Hippel-Lindau (VHL)-mediated Degradation Pathway
Huang, E. L., Pete, E. A., Schau, M., Milligan, J., & Gu, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207280200 · Cited by 38
Henríquez, J. A., Sleeman, J. P., & Garvalov, B. K. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9930-x · Cited by 37
Vaux, E. C., Wood, S. M., Cockman, M. E., Nicholls, L. G., Yeates, K. M., Pugh, C. W., Maxwell, P. H., & Ratcliffe, P. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104678200 · Cited by 37
Metabolic regulation of oxygen and redox homeostasis by p53: Lessons from evolutionary biology?
Zhuang, J., Ma, W., Lago, C. U., & Hwang, P. M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.07.026 · Cited by 37
Kim, H., Kim, H., Kong, J. M., Bae, S., Kim, Y. S., Lee, N., Cho, B. J., Lee, S. K., Kim, H., Hwang, Y., et al. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22997 · Cited by 36
The Role of Hypoxia Inducible Factor-1 Alpha in Bypassing Oncogene-Induced Senescence
Eren, M. K., & Tabor, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101064 · Cited by 35
Tumour vasculature targeting agents in hybrid/conjugate drugs
Prokopiou, E., Ryder, S. A., & Walsh, J. J. (2013) · Angiogenesis · doi:10.1007/s10456-013-9347-8 · Cited by 36
Karsy, M. J., Guan, J., Jensen, R. L., Huang, E. L., & Colman, H. (2015) · World Neurosurgery · doi:10.1016/j.wneu.2015.12.032 · Cited by 40
Mitochondrial Aldehyde Dehydrogenase 2 Regulates Revascularization in Chronic Ischemia
Liu, X., Sun, X., Liao, H., Dong, Z., Zhao, J., Zhu, H., Wang, P., Shen, L., Xu, L., Ma, X., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306012 · Cited by 36
Shimomura, M., Hinoi, T., Kuroda, S., Adachi, T., Kawaguchi, Y., Sasada, T., Takakura, Y., Egi, H., Okajima, M., Tashiro, H., et al. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-2945-2 · Cited by 36
Negative regulation of hypoxia inducible factor‐1α by necdin
Moon, H.-E., Ahn, M.-Y., Park, J. A., Min, K., Kwon, Y., & Kim, K.-W. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.05.072 · Cited by 36
When hypoxia signalling meets the ubiquitin-proteasomal pathway, new targets for cancer therapy
Brahimi‐Horn, C., & Pouysségur, J. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.09.003 · Cited by 38
The Vascular-Ablative Agent VEGF121/rGel Inhibits Pulmonary Metastases of MDA-MB-231 Breast Tumors
Ran, S., Mohamedali, K. A., Luster, T. A., Thorpe, P. E., & Rosenblum, M. G. (2005) · Neoplasia · doi:10.1593/neo.04631 · Cited by 36
Hypoxia-Inducible Factors: Post-translational Crosstalk of Signaling Pathways
Dimova, E. Y., & Kietzmann, T. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-738-9_13 · Cited by 35
Sharma, N. M., Cunningham, C., Zheng, H., Liu, X., & Patel, K. P. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.116.003423 · Cited by 37
Kaynar, M. Y., Sanuş, G. Z., Hnimoglu, H., Kaçıra, T., Kemerdere, R., Atukeren, P., Gümüştaş, K., Canbaz, B., & Tanrıverdi, T. (2008) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2007.07.080 · Cited by 34
Is Oncogene Addiction Angiogenesis-dependent?Preprint
Folkman, J., & Ryeom, S. W. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.042 · Cited by 35
Disruptive chemicals, senescence and immortality
Carnero, A., Blanco‐Aparicio, C., Kondoh, H., LLeonart, M. E., Martínez-Leal, J. F., Mondello, C., Scovassi, A. I., Bisson, W. H., Amedei, A., Roy, R., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv029 · Cited by 36
Renal Cell Carcinoma Development and miRNAs: A Possible Link to the EGFR Pathway
Dias, F., Teixeira, A. L., Santos, J. I., Gomes, M. P., Nogueira, A., Assis, J., & Medeiros, R. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.184 · Cited by 35
Tumor suppressor protein p53 negatively regulates ischemia-induced angiogenesis and arteriogenesis
Pfaff, M. J., Mukhopadhyay, S., Hoofnagle, M. H., Chabasse, C., & Sarkar, R. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2018.02.055 · Cited by 34
Carrera, S., Senra, J. M., Acosta, M. I., Althubiti, M., Hammond, E. M., de Verdier, P. J., & Macip, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097938 · Cited by 37
Transcriptional repression of the human p53 gene by cobalt chloride mimicking hypoxia
Lee, S., Lee, H., & Rho, H. M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02989-1 · Cited by 34
Clere, N., Bermont, L., Fauconnet, S., Lascombe, I., Saunier, M., Vettoretti, L., Plissonnier, M., & Mougin, C. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.06.029 · Cited by 39
Extracellular vesicles in cancers: mechanisms, biomarkers, and therapeutic strategies
Ma, Y., Zhang, X., Liu, C., & Zhao, Y. (2024) · MedComm · doi:10.1002/mco2.70009 · Cited by 38
Environmental factors in breast cancer invasion: a mathematical modelling review
Simmons, A., Burrage, P., Nicolau, D. V., Lakhani, S. R., & Burrage, K. (2017) · Pathology · doi:10.1016/j.pathol.2016.11.004 · Cited by 35
Involvement of E3 Ligases and Deubiquitinases in the Control of HIF-α Subunit Abundance
Kubaichuk, K. I., & Kietzmann, T. (2019) · Cells · doi:10.3390/cells8060598 · Cited by 34
Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinoma
Sethi, N. S., Kikuchi, O., McFarland, J. M., Zhang, Y., Chung, M., Kafker, N., Islam, M., Lampson, B. L., Chakraborty, A. A., Kaelin, W. G., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.128439 · Cited by 35
Kuijper, A., van der Groep, P., van der Wall, E., & van Diest, P. J. (2005) · Breast Cancer Research · doi:10.1186/bcr1296 · Cited by 35
p53 Promotes proteasome-dependent degradation of oncogenic protein HBx by transcription of MDM2
Xian, L., Zhao, J., Wang, J., Fang, Z., Peng, B., Wang, W., Ji, X., & Yu, L. (2009) · Molecular Biology Reports · doi:10.1007/s11033-009-9855-1 · Cited by 33
The relevance of protein-protein interactions for p53 function: the CPE contribution
Fernández-Fernández, M. R., & Sot, B. (2010) · Protein Engineering Design and Selection · doi:10.1093/protein/gzq074 · Cited by 33
Sutton, T. A., Wilkinson, J., Mang, H. E., Knipe, N. L., Plotkin, Z., Hosein, M., Zak, K., Wittenborn, J., & Dagher, P. C. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90304.2008 · Cited by 33
Novel Histopathological Biomarkers in Prostate Cancer: Implications and Perspectives
Kiełb, P., Kowalczyk, K., Gurwin, A., Nowak, Ł., Krajewski, W. R., Sosnowski, R., Szydełko, T., & Małkiewicz, B. (2023) · Biomedicines · doi:10.3390/biomedicines11061552 · Cited by 35
Toxic Diatom Aldehydes Affect Defence Gene Networks in Sea Urchins
Varrella, S., Romano, G., Costantini, S., Ruocco, N., Ianora, A., Bentley, M. G., & Costantini, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149734 · Cited by 32
Vigneshwaran, V., Thirusangu, P., Madhusudana, S., Krishna, V., Pramod, S. N., & Prabhakar, B. T. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.07.024 · Cited by 32
HIF-Dependent Mechanisms of Relationship between Hypoxia Tolerance and Tumor Development
Dzhalilova, D. S., & Makarova, O. V. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921100011 · Cited by 34
Cerebral Oxygen Delivery and Consumption in Brain-Injured Patients
Siwicka-Gieroba, D., Robba, C., Gołacki, J., Badenes, R., & Dąbrowski, W. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111763 · Cited by 32
Cimmino, F., Pezone, L., Avitabile, M., Acierno, G., Andolfo, I., Capasso, M., & Iolascon, A. (2015) · Scientific Reports · doi:10.1038/srep11158 · Cited by 31
Renal cancer: Oxygen meets metabolism
Haase, V. H. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.02.026 · Cited by 34
Tumor suppressor protein p53 induces degradation of the oncogenic protein HBx
Park, S., Min, J. Y., Chung, C., Hsieh, A., & Jung, G. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.03.019 · Cited by 33
Mitoxantrone Inhibits HIF-1α Expression in a Topoisomerase II–Independent Pathway
Toh, Y.-M., & Li, T.-K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0235 · Cited by 32
Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoter
Longo, S. L., Griffith, C. C., Glass, A. M., Shillitoe, E. J., & Post, D. E. (2010) · Cancer Gene Therapy · doi:10.1038/cgt.2010.62 · Cited by 32
Pharmacological activation of a novel p53-dependent S-phase checkpoint involving CHK-1
Ahmed, A., Yang, J., Maya‐Mendoza, A., Jackson, D. A., & Ashcroft, M. A. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.42 · Cited by 31
14-3-3ζ Orchestrates Mammary Tumor Onset and Progression via miR-221–Mediated Cell Proliferation
Rehman, S. K., Li, S.-H., Wyszomierski, S. L., Wang, Q., Li, P., Şahin, Ö., Xiao, Y. Q., Zhang, S., Xiong, Y., Yang, J., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2016 · Cited by 31
The Roles of Cullin-2 E3 Ubiquitin Ligase Complex in Cancer
Liu, X., Zurlo, G., & Zhang, Q. H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1025-0_11 · Cited by 32
Reactivation of Epstein-Barr Virus by HIF-1α Requires p53
Kraus, R. J., Cordes, B.-L. A., Sathiamoorthi, S., Patel, P., Yuan, X., Iempridee, T., Yu, X., Lee, D. L., Lambert, P. F., & Mertz, J. E. (2020) · Journal of Virology · doi:10.1128/jvi.00722-20 · Cited by 32
Diabetes and Its Cardiovascular Complications: Potential Role of the Acetyltransferase p300
Pietrantonio, N. D., Tomo, P. D., Mandatori, D., Formoso, G., & Pandolfi, A. (2023) · Cells · doi:10.3390/cells12030431 · Cited by 31
Rademakers, S. E., Hoogsteen, I. J., Rijken, P. F. J. W., Oosterwijk, E., Terhaard, C. H. J., Doornaert, P., Langendijk, J. A., van den Ende, P. L. A., Takes, R. P., de Bree, R., et al. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.04.022 · Cited by 30
Chen, L., Wu, Y., Liu, P., Wang, J., Wang, G., Jin, Q., Zhou, J., & Zhu, J. (2011) · Medical Oncology · doi:10.1007/s12032-010-9690-1 · Cited by 31
Hypoxia-inducible factors: Crosstalk between their protein stability and protein degradation
Wei, W., & Yu, X. D. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.08.009 · Cited by 33
Anti-Angiogenic Therapy: Prospects for Treatment of Ocular Tumors
Rosenblatt, M. I., & Azar, D. T. (2006) · Seminars in Ophthalmology · doi:10.1080/08820530500350787 · Cited by 31
Preclinical MRI Experience in Imaging Angiogenesis
Neeman, M. (2000) · Cancer and Metastasis Reviews · doi:10.1023/a:1026583911941 · Cited by 31
Lee, S.-H., Kang, J. H., Ha, J. S., Lee, J., Oh, S. J., Choi, H.-J., Song, J., & Kim, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145042 · Cited by 30
p53 codon 72 polymorphism and breast cancer risk: A meta-analysis
Hou, J. Y., Jiang, Y. Z., Tang, W., & Jia, S. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1019 · Cited by 30
Liu, F., Lin, B., Liu, X., Zhang, W., Zhang, E., Hu, L., Ma, Y., Li, X., & Tang, X. (2016) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504015x14496932933610 · Cited by 30
Brain metastases: Biology and the role of the brain microenvironment
Puduvalli, V. K. (2001) · Current Oncology Reports · doi:10.1007/s11912-001-0067-7 · Cited by 30
King, M. J., Bukantz, S. C., Phillips, S. E., Mohapatra, S. S., Tamulis, T., & Lockey, R. F. (2004) · PubMed · Cited by 30
A BMAL1 mutant with arginine 91 substituted with alanine acts as a dominant negative inhibitor
Hosoda, H., Motohashi, J., Kato, H., Masushige, S., & Kida, S. (2004) · Gene · doi:10.1016/j.gene.2004.05.022 · Cited by 30
Chowdhury, A. R., Long, A., Fuchs, S. Y., Rustgi, A. K., & Avadhani, N. G. (2016) · Oncogene · doi:10.1038/onc.2016.211 · Cited by 29
Anti-Cancer Activity of Phytochemicals Targeting Hypoxia-Inducible Factor-1 Alpha
Yun, B. D., Son, S. W., Choi, S. Y., Kuh, H. J., Oh, T., & Park, J. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189819 · Cited by 31
Metadata
- Authors
- Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A.
- Affiliations
- Johns Hopkins University (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2000-01-01
- Volume
- 14
- Issue
- 1
- Pages
- 34-44
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W4294718043
- Semantic Scholar
- 5c0770cda1be256df47794076979768b0350af33
- Cited by
- 967
- References
- 70
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 35 · 2023: 28 · 2022: 35 · 2021: 35 · 2020: 33 · 2019: 25 · 2018: 30 · 2017: 25 · 2016: 35 · 2015: 41 · 2014: 36 · 2013: 34 · 2012: 32
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- Funders
- U.S. Department of Defense
- American Cancer Society
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- tumor angiogenesis, p53, hypoxia-inducible factor-1α, MDM2, ubiquitination, proteasomal degradation, vascular endothelial growth factor, hypoxia, neovascularization, tumor xenografts, angiogenic switch, tumor suppressor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
